Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emboline Inc.

Complete aortic embolic protection with tool access

This article was originally published in Start Up

Executive Summary

While the focus of aortic embolic protection has previously been limited to stroke prevention, Emboline Inc. believes the concern should be broader because there are other complications that can be caused by emboli moving downstream, resulting in diminished function or failure of other organs, such as the kidneys. The company’s Emboline CAP device provides complete protection of the arterial system from these emboli, thanks to a central filter enabled by an access port that allows for tool access through the filter.

You may also be interested in...



Minute Insight: Medtronic Brings Hugo RAS To Canada

Health Canada has licensed Hugo for urologic and gynecologic laparoscopic surgical procedures.

Finance Watch: Biopharma IPOs Slow But SPACs Back On The Go

Public Company Edition: It has been almost a month since a biopharma firm launched an IPO in the US, but special purpose acquisition corporations continue to take drug makers public, including Alvotech and Aerami. Outside the US, MaaT closed an IPO in Paris and BeiGene priced a Shanghai offering.

Cosmetic And Personal Care Trademark Review 7 December, 2021

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

MT037757

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel